文献速递类风湿关节炎血管炎

类风湿关节炎对合并与不合并冠心病患者主要心血管事件的影响

Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease.
PubMed 文献 · Ann Rheum Dis · 2020-05-29

结果显示,无论是否合并冠心病,类风湿关节炎均与10年心肌梗死、主要不良心血管事件及全因死亡风险显著相关;同时合并类风湿关节炎与冠心病者风险最高,而无冠心病者中类风湿关节炎的附加风险较小。

要点

  • 类风湿关节炎患者无论是否合并冠心病,10年心肌梗死、MACE及全因死亡风险均显著升高。
  • 同时合并类风湿关节炎与冠心病者风险最高,10年心肌梗死累积发生率达12.2%。
  • 无冠心病者中类风湿关节炎的附加风险较小,10年心肌梗死累积发生率为3.8%。

核心结论

  • 在接受冠状动脉造影的患者中,类风湿关节炎与10年心肌梗死、主要不良心血管事件及全因死亡风险显著相关,且不受是否合并冠心病影响。
  • 同时合并类风湿关节炎与冠心病者风险最大,而无冠心病者中类风湿关节炎的附加风险较小。

研究设计与样本

  • 基于丹麦西部心脏注册的人群队列研究,纳入2003至2016年间接受冠状动脉造影的患者,按类风湿关节炎与冠心病状态分层。

主要发现

  • 以既无类风湿关节炎也无冠心病者为参照(心肌梗死累积发生率2.7%),单纯类风湿关节炎者10年心肌梗死风险升高(3.8%;调整发病率比1.63,95%CI 1.04至2.54)。
  • 单纯冠心病者10年心肌梗死累积发生率为9.9%(调整发病率比3.35,95%CI 3.10至3.62)。
  • 同时合并类风湿关节炎与冠心病者10年心肌梗死累积发生率最高,达12.2%(调整发病率比4.53,95%CI 3.66至5.59)。
  • 主要不良心血管事件及全因死亡观察到与心肌梗死相似的关联。

关键数值与推荐

  • 终点包括心肌梗死、主要不良心血管事件(心肌梗死、缺血性卒中及心源性死亡)及全因死亡。
  • 以既无类风湿关节炎也无冠心病者为参照,其心肌梗死累积发生率为2.7%。

临床怎么用

  • 对类风湿关节炎患者,可根据是否存在明确冠心病进行风险分层,以指导筛查和个体化治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Rheumatoid arthritis (RA) is a risk factor for cardiovascular disease. The clinical consequences of coincident RA and coronary artery disease (CAD) are unknown. OBJECTIVE: We aimed to estimate the impact of RA on the risk of adverse cardiovascular events in patients with and without CAD. METHODS: A population-based cohort of patients registered in the Western Denmark Heart Registry, who underwent coronary angiography (CAG) between 2003 and 2016, was stratified according to the presence of RA and CAD. Endpoints were myocardial infarction (MI), major adverse cardiovascular events (MACE; MI, ischaemic stroke and cardiac death) and all-cause mortality. RESULTS: A total of 125 331 patients were included (RA: n=1732). Median follow-up was 5.2 years. Using patients with neither RA nor CAD as reference (cumulative MI incidence 2.7%), the 10-year risk of MI was increased for patients with RA alone (3.8%; adjusted incidence rate ratio (IRRadj) 1.63, 95% CI 1.04 to 2.54), for patients with CAD alone (9.9%; IRRadj 3.35, 95% CI 3.10 to 3.62), and highest for patients with both RA and CAD (12.2%; IRRadj 4.53, 95% CI 3.66 to 5.59). Similar associations were observed for MACE an all-cause mortality. CONCLUSIONS: In patients undergoing CAG, RA is significantly associated with the 10-year risk of MI, MACE and all-cause mortality regardless of the presence of CAD. However, patients with RA and CAD carry the largest risk, while the additive risk of RA in patients without CAD is minor. Among patients with RA, risk stratification by presence or absence of documented CAD may allow for screening and personalised treatment strategies.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Løgstrup BB, Olesen KKW, Masic D, et al. Impact of rheumatoid arthritis on major cardiovascular events in patients with and without coronary artery disease. Ann Rheum Dis. 2020. PMID: 32471895. doi:10.1136/annrheumdis-2020-217154

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。